[HTML][HTML] A review of biological targets and therapeutic approaches in the management of triple-negative breast cancer

H Kumar, NV Gupta, R Jain… - Journal of Advanced …, 2023 - Elsevier
Background Triple-negative breast cancer (TNBC) is a heterogeneous, aggressive
phenotype of breast cancer with associated chemoresistance. The development of chemo-or …

Receptor tyrosine kinase inhibitors in cancer

N Ebrahimi, E Fardi, H Ghaderi, S Palizdar… - Cellular and Molecular …, 2023 - Springer
Targeted therapy is a new cancer treatment approach, involving drugs that particularly target
specific proteins in cancer cells, such as receptor tyrosine kinases (RTKs) which are …

Mechanism insights of curcumin and its analogues in cancer: An update

P Joshi, K Verma, D Kumar Semwal… - Phytotherapy …, 2023 - Wiley Online Library
Cancer is the world's second leading cause of mortality and one of the major public health
problems. Cancer incidence and mortality rates remain high despite the great …

Antioxidant Metabolism Pathways in Vitamins, Polyphenols, and Selenium: Parallels and Divergences

CMC Andrés, JM Pérez de la Lastra, CA Juan… - International Journal of …, 2024 - mdpi.com
Free radicals (FRs) are unstable molecules that cause reactive stress (RS), an imbalance
between reactive oxygen and nitrogen species in the body and its ability to neutralize them …

Vascular endothelial growth factor ligands and receptors in breast cancer

KK Brogowska, M Zajkowska, B Mroczko - Journal of Clinical Medicine, 2023 - mdpi.com
Breast cancer (BC) is the most common malignancy responsible for the largest number of
deaths in women worldwide. The risk of developing BC is predisposed by many factors such …

Applications of curcumin and its nanoforms in the treatment of cancer

D Mundekkad, WC Cho - Pharmaceutics, 2023 - mdpi.com
Due to the diverse medicinal and pharmacokinetic properties of turmeric, it is well-known in
the therapeutic, pharmaceutic, nutraceutical, cosmetic, and dietary industries. It gained …

Sigma-1 receptor signaling: in search of new therapeutic alternatives for cardiovascular and renal diseases

FJ Munguia-Galaviz, AG Miranda-Diaz… - International journal of …, 2023 - mdpi.com
Cardiovascular and renal diseases are among the leading causes of death worldwide, and
regardless of current efforts, there is a demanding need for therapeutic alternatives to …

Targeting HER3 to overcome EGFR TKI resistance in NSCLC

Q Chen, G Jia, X Zhang, W Ma - Frontiers in Immunology, 2024 - frontiersin.org
Receptor tyrosine kinases (RTKs) play a crucial role in cellular signaling and oncogenic
progression. Epidermal growth factor receptor tyrosine kinase inhibitors (EGFR TKIs) have …

Exosome-mediated response to cancer therapy: Modulation of epigenetic machinery

MI Khan, RKME Alsayed, H Choudhry… - International Journal of …, 2022 - mdpi.com
Exosomes, the extracellular vesicles produced in the endosomal compartments, facilitate the
transportation of proteins as well as nucleic acids. Epigenetic modifications are now …

miRNA Expression Profiling in Human Breast Cancer Diagnostics and Therapy

I Dziechciowska, M Dąbrowska, A Mizielska… - Current Issues in …, 2023 - mdpi.com
Breast cancer is one of the most commonly diagnosed cancer types worldwide. Regarding
molecular characteristics and classification, it is a heterogeneous disease, which makes it …